"
Team:Paris/safety
From 2009.igem.org
(→Safety) |
(→Safety) |
||
| Line 3: | Line 3: | ||
{{Template:Paris2009_menu}} | {{Template:Paris2009_menu}} | ||
| - | ==Safety== | + | ==Overview== |
| + | |||
| + | As an emerging technology, Synthetic Biology raises new technical and scientific challenges but also questions for ethics, biosafety, biosecurity and intellectual property. | ||
| + | As one of the stakeholder of Synthetic biology, our team lead a open-discussion at the Lab about these questions. You can find our work in the wiki in [[https://2009.igem.org/Team:Paris/Ethics_overview#top Ethic part]]. | ||
| + | |||
| + | |||
| + | <iframe src="http://docs.google.com/present/embed?id=dszgzt9_236dv4ncqcs&autoStart=true&loop=true" frameborder="0" width="410" height="342"></iframe> | ||
| + | |||
| + | |||
| + | ===Safety=== | ||
| + | |||
The work has been carried out in the laboratory of Molecular, Evolutive and Medical Genetics Unit (U571) of the French National Institute of Medical Research (INSERM) within the Paris Descartes University's Medical faculty. Thus, the work was inspected both by the University's Safety officer (last surprise visit 18 Oct went smoothly with the only caveat being paper boxes on ther top shelf above the bench that needed to be removed...). More importantly, the biosafety officer of our unit followed our work. | The work has been carried out in the laboratory of Molecular, Evolutive and Medical Genetics Unit (U571) of the French National Institute of Medical Research (INSERM) within the Paris Descartes University's Medical faculty. Thus, the work was inspected both by the University's Safety officer (last surprise visit 18 Oct went smoothly with the only caveat being paper boxes on ther top shelf above the bench that needed to be removed...). More importantly, the biosafety officer of our unit followed our work. | ||
Both institutions have their ethical committees though no specific issue concerning our project needed to be raised. Nonetheless, a thorough work was done throughout this period regarding general safety and ethical issues not only specific to our work (including declining other ideas of projects that might have had potential future hazard). This is detailed within the Ethics part of our wiki documentation. Click here for more [[https://2009.igem.org/Team:Paris/Ethics_overview#Ethics_:_Overview Ethics and Biosafety]] | Both institutions have their ethical committees though no specific issue concerning our project needed to be raised. Nonetheless, a thorough work was done throughout this period regarding general safety and ethical issues not only specific to our work (including declining other ideas of projects that might have had potential future hazard). This is detailed within the Ethics part of our wiki documentation. Click here for more [[https://2009.igem.org/Team:Paris/Ethics_overview#Ethics_:_Overview Ethics and Biosafety]] | ||
| + | |||
| + | |||
| + | Draft idea | ||
| + | on n a pas commander de sequence toxique | ||
| + | on a eu des idées touchant biosafety : meningtis ou deinoccocus | ||
| + | |||
| + | risk assesment in synthetic biology | ||
| + | |||
| + | impcat de la modelisation | ||
| + | |||
| + | our role after iGEM competition | ||
Revision as of 02:55, 22 October 2009
Overview
As an emerging technology, Synthetic Biology raises new technical and scientific challenges but also questions for ethics, biosafety, biosecurity and intellectual property. As one of the stakeholder of Synthetic biology, our team lead a open-discussion at the Lab about these questions. You can find our work in the wiki in [Ethic part].
<iframe src="http://docs.google.com/present/embed?id=dszgzt9_236dv4ncqcs&autoStart=true&loop=true" frameborder="0" width="410" height="342"></iframe>
Safety
The work has been carried out in the laboratory of Molecular, Evolutive and Medical Genetics Unit (U571) of the French National Institute of Medical Research (INSERM) within the Paris Descartes University's Medical faculty. Thus, the work was inspected both by the University's Safety officer (last surprise visit 18 Oct went smoothly with the only caveat being paper boxes on ther top shelf above the bench that needed to be removed...). More importantly, the biosafety officer of our unit followed our work. Both institutions have their ethical committees though no specific issue concerning our project needed to be raised. Nonetheless, a thorough work was done throughout this period regarding general safety and ethical issues not only specific to our work (including declining other ideas of projects that might have had potential future hazard). This is detailed within the Ethics part of our wiki documentation. Click here for more [Ethics and Biosafety]
Draft idea
on n a pas commander de sequence toxique
on a eu des idées touchant biosafety : meningtis ou deinoccocus
risk assesment in synthetic biology
impcat de la modelisation
our role after iGEM competition
